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Abstract
Background:
The aim of this study was to explore the associations between physical symptoms, sleep disturbances, and
depressive symptoms in community-dwelling elderly individuals, comparing persons with and without heart
failure (HF).
Methods:
A total of 613 older adults (mean age 78 years) underwent clinical and echocardiographic examinations.
Questionnaires were used to evaluate sleep disturbances and depressive symptoms. A model was developed in
those with HF (n = 107) and compared with those without HF (n = 506).
Results:
Cardiopulmonary symptoms (ie, dyspnea and nighttime palpitations) and pain had significant direct
associations with sleep disturbances, which indirectly affected depressive symptoms. The model was
essentially the same in those with and without HF except that the effect of sleep disturbances on depressive
symptoms was stronger in those with HF (β = 0.64 vs β = 0.45, P = .006).
Conclusion:
In community-dwelling older adults, regardless of their diagnosis, physical symptoms had a direct effect on
sleep disturbances and an indirect effect on depressive symptoms.
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Abstract 
Background: The aim of this study was to explore the associations between physical 
symptoms, sleep disturbances and depressive symptoms in community dwelling elders, 
comparing persons with and without heart failure (HF). 
Methods: 613 older adults (mean age 78 years) underwent clinical and echocardiographic 
examination. Questionnaires were used to evaluate sleep disturbances and depressive 
symptoms. A model was developed in those with HF (n=107) and compared in those without 
HF (n=506). 
Results: Cardiopulmonary symptoms (i.e. dyspnoea and night-time palpitations) and pain had 
significant direct associations with sleep disturbances, which indirectly affected depressive 
symptoms. The model was essentially the same in those with and without HF except that the 
effect of sleep disturbances on depressive symptoms was stronger in those with HF (β=0.64 
vs. β=0.45, p=0.006). 
Conclusion: In community dwelling older adults, regardless of their diagnosis, physical 
symptoms had a direct effect on sleep disturbances and an indirect effect on depressive 
symptoms.  
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Background 
Chronic heart failure (HF) is common in the general population and the prevalence rises with 
age.1 Today the mean age for community dwelling HF patients is at least 75 years.2 In patients 
with HF, both sleep disturbances3 and depression are common.4 Sleep disturbances and 
depression seem to be intertwined. Treatment of depression usually improves sleep, whereas 
treatment of insomnia can decrease the risk of relapse or recurrence of depression.5 
The symptoms of insomnia, including difficulties maintaining sleep (DMS), difficulties 
initiating sleep (DIS), and non restorative sleep (NRS) are commonly reported by the general 
population.8 In a survey of adults older than 18 years, 21% complained of DIS, 16% of DMS, 
and 11% of NRS at least three times a week during the last month or more.9 In Sweden, where 
this study was conducted on adults aged 65-79 years, 36%, 43% and 32% reported complaints 
of DIS, DMS and NRS.10 Sleep problems are particularly prevalent in HF patients, with 
almost 60% reporting trouble sleeping or not getting enough of sleep at least 3-4 times a 
week.3 In a study by Broström et al.13 DMS was the most commonly reported insomnia 
symptom, with major complaints reported by 23% of the men and 20% of the women.  
As people age, sleep becomes even more fragmented with increasing amounts of time spent in 
superficial sleep non rapid eye movement sleep (NREM) stage 1 and 2, less time in deep, 
slow wave sleep (NREM stage 3 and 4) and rapid eye movement sleep (REM) sleep 6. Signs 
of disrupted circadian regulation of sleep can also be seen with aging, with older people 
tending to experience increased sleep onset latency, more nightly awakenings, and a 
decreased total sleep time compared to younger people.7 Physical symptoms may be 
responsible for some of the sleep disturbances experienced with aging. Symptoms such as 
dyspnoea, palpitations and pain commonly disturb sleep in HF patients.15-16 However, many 
of these problems are responsible for disturbed sleep in older adults without HF as well.17-18  
Another health problem common in the general population that is associated with aging and 
linked to sleep disturbances is depressive symptoms such as anhedonia, lack of energy and 
weight changes.11 In a Norwegian epidemiological study Stordal et al. found that the 
occurrence of depressive symptoms as measured by the Hospital Anxiety Depression scale 
(HADS) increased from 4% of men and women aged 20-29 years, to 14% of those aged 60-69 
years, to 17% of those aged 70-79 years. In those aged 80-89 years, depressive symptoms 
were found in 23% of the men and 18% of the women.12 Approximately 30-40% of HF 
patients have depressive symptoms.19 Factors known to predict depressive symptoms in HF 
patients include poor health perceptions, alcohol abuse, economic burden associated with 
medical care and living alone. However, not all of the depressive symptoms of HF can be 
explained by this aggregate.20 Disturbed sleep confers approximately a two to threefold 
increase in the risk of depressive symptoms in HF patients.14 Importantly, depressive 
symptoms have been found to mediate the effects of sleep disturbances on health related 
quality of life.11 
The relationships between physical symptoms, sleep disturbances, and depressive symptoms 
have not been extensively evaluated in community dwelling older adults with or without HF. 
Knowledge about these associations is important in the design of interventions. If these 
relationships are only evident in HF patients, HF programs should integrate approaches 
designed to improve sleep and/or depressive symptoms. But, if these relationships are generic 
in all older adults, interventions can be designed to address physical symptoms, regardless of 
the medical diagnosis. The aim of this study therefore was to explore the associations between 
physical symptoms, sleep disturbances, and depressive symptoms in community dwelling 
older adults with and without HF. 
 
Methods 
Sample 
The patient population was derived from the CoroKind study and has been described 
previously.21 In brief, the major aim of the parent study was to evaluate the prevalence of HF 
among community dwelling older adults. The study took place between 1998 to 2000. All 
subjects were aged 65-82 years and lived in a rural community with 10 300 inhabitants in the 
southeast of Sweden. All inhabitants in the age span mentioned above were invited to clinical 
and echocardiographic examinations. The rationale for this unusual age span is that some 
people agreed to participate only if their younger or older spouse could be examined as well. 
Of 1130 individuals in the targeted age range, 876 agreed to participate (participation rate 
78%). From January 2003 to June 2005 the cohort was again contacted by telephone by a 
research nurse and invited to repeat their clinical and echocardiographic examinations. A total 
of 675 subjects (77% of the original cohort) agreed to participate. The reasons for not 
participating were death (12%), having moved to nursing homes or other parts of Sweden 
(3%), declined (7%) and not showing up (1%). All participants provided informed written 
consent. The study protocol was approved by the Ethics Committee at the Faculty of Health 
Sciences, University of Linköping, Sweden, and is in accordance with the provisions of the 
Helsinki declaration. 
Clinical Examination 
For this follow-up study all participants were examined by a cardiologist and given a package 
of self-report instruments to be returned by mail. The cardiologist took a patient history and 
performed a clinical examination, including symptoms and signs of HF. To reduce bias, the 
cardiologist was blinded to the results of the prior examinations and echocardiography. 
Doppler echocardiographic examinations were performed to assess left ventricular ejection 
fraction (LVEF). Global systolic function was determined semi-quantitatively and classified 
into three groups. In this study, LVEF ≥ 50% corresponded to normal systolic function and 
LVEF≤ 49% corresponded to at least mildly impaired systolic function. In the present study, 
the cardiologists in the author group (UA and UD) assessed the presence of HF. All subjects 
who had at least mildly impaired systolic function (LVEF <=49%) and had clinical signs and 
symptoms of HF were considered to have HF. 
 
Individual comorbid conditions were identified by the cardiologist during the clinical 
examination. Diabetes mellitus was defined as ongoing treatment for diabetes or fasting blood 
glucose ≥ 7 mmol/L. Hypertension was defined as a previous physician diagnosis or blood 
pressure of more than 140/90 mm Hg. Ischemic heart disease (IHD) was defined as a history 
of angina pectoris and/or myocardial infarction and/or coronary angioplasty and/or coronary 
bypass surgery. Previous or present tumour was defined by history. A respiratory disease was 
established if the participant had a diagnosis of or was undergoing treatment for chronic 
pulmonary disease or asthma. 
Physical signs and symptoms and Sleep disturbances 
Items from the 26 item Uppsala Sleep Inventory (USI)-HF questionnaire were used to 
measure physical symptoms and sleep disturbances.13 The USI has previously been used in 
surveys of both younger and elderly people, as well as in patients with HF. 10, 13, 22 In 
development, the content in the USI-HF was scrutinized and revised by an expert panel 
consisting of sleep researchers, cardiologist and HF nurses. The USI-HF measures five 
dimensions: sleep complaints; physical and emotional arousals; daytime symptoms; sleep 
need; and sleep disruption. Chronbach alpha has been reported to be 0.75.13 In the present 
study items measuring the insomnia symptoms of DIS, DMS and NRS were used. On these 
items the respondents rate their problems on a Likert scale ranging from no problems (1) 
small problems (2) moderate problems (3) great problems (4) to very great problems (5). 
Estimates of the number of nocturnal awakenings and hypnotic uses were also included as 
indicators of sleep disturbances.The USI-HF items measuring problems with nocturnal 
dyspnoea, palpitations and pain were used as indicators of physical symptoms. These items 
are answered as never (1) seldom (2) sometimes (3) often (4) or very often (5).  
Depressive symptoms 
Depressive symptoms were measured with the Hospital Anxiety Depression scale (HADS).23 
To prevent noise from somatic diseases the instrument only focuses the affective symptoms of 
depression (i.e. depressed, sad mood and diminished interest or pleasure in activities).23 The 
HADS is frequently used in different types of settings (e.g., community care, primary care 
and hospital wards) and in different patient groups.24 The HADS scores range from 0-21, with 
higher scores indicating more symptoms of depression.23 The HADS has been found to be a 
reliable tool. Psychometric testing supports two factor solution (anxiety and depression). The 
sensitivity and specificity was approximately 0.80 for both subscales,30 supporting 
discriminant validity of the HADS. Chronbach’s alpha for the HADS was 0.82.30 In the 
present study the HADS was used as a continuous measure in statistical analyses. 
Statistical analysis 
Both descriptive statistics and structural equation modeling (SEM) were used to analyse the 
data in the present study. Spearman correlation was used to analyse the bivariate associations 
between the manifest variables representing physical symptoms, sleep disturbances and 
depressive symptoms. SEM was used to explore the relationships between physical 
symptoms, sleep disturbances and depressive symptoms in participants with and without HF.  
SEM was used because it permits analysis and modeling of complex inter-relationships 
among a number of inter-dependent variables. In the SEM analysis measured variables are 
factored to latent variables and assumed paths between the constructs are tested. A conceptual 
model of the associations of physical symptoms, sleep disturbances and depressive symptoms 
was developed based on earlier HF studies and used to guide the SEM analysis.3, 14-16, 25 In 
this theoretical model we assumed that HF was a cause for the physical symptoms of 
dyspnoea, palpitations, pain. These symptoms were assumed to be linked with depressive 
symptoms through the symptoms of insomnia, nocturnal awakenings, and use of hypnotics. 
The summary score from the HADS was used to indicate depressive symptoms.  
The model of physical symptoms (i.e. dyspnoea, palpitations and pain), sleep disturbances 
and depressive symptoms was tested in participants with and without HF using SEM. 
Associations between the latent variables were derived using maximum likelihood and 
described with their standardized coefficients.To assess goodness of fit we used the chi-square 
value, the Root Mean Square Error of Approximation (RMSEA) and the Comparative Fit 
Index (CFI). In general terms fit indices provide estimates of how well the model would 
represent our population of community dwelling elderly with and without HF. An 
insignificant chi-square would indicate a good model fit. An overall RMSEA below 0.06 
indicates a good fit whereas a CFI ≥ 0.95 is considered a good fit indicating that at least 95 
percent of the covariation in the data is reproduced by the model. Modification indices were 
used to modify the model only if these modifications were theoretically justified. The 
modification index estimates the decrease in the chi-square value that would result if a given 
parameter is added to the model.26 
Descriptive and comparative analyses were performed with the SPSS version 18.0 whereas 
SEM analyses were performed with the LISREL 8.30 software. A p < 0.05 in the SPSS 
analyses and t-value of ≥ 1.96 for factor loadings and effects in the LISREL analyses were 
considered significant. 
 
Results 
Of 675 participants investigated, a total of 613 (91%) had data on echocardiography, physical 
symptoms, sleep disturbances and depressive symptoms available for analysis. Table 1 
describes baseline characteristics of the studied sample. The mean age of sample was 78 years 
and 47% were males. A total of 107 participants (17%) clearly had HF; these participants with 
HF were older (79 years vs. 77 years, p=0.001) and more of them were male (71% vs. 43%, 
p=0.001) compared to those without HF. Those with HF had higher median plasma creatinine 
concentration (84 µmol/L vs. 73 µmol/L, p=0.001) and more diabetes (25% vs. 14%, 
p=0.005) and ischemic heart disease (50% vs. 21%, p=0.001) than those without HF. More of 
those with HF had two or more co-morbidities (64% vs. 36%, p=0.001) and had more 
treatment with ACE/ARB (39% vs. 23%, p=0.001), B-blockers (55% vs. 32%, p=0.001) and 
diuretics 46% vs. 33%, p=0.012). No differences between those with and without HF were 
found regarding antidepressant medication and hypnotic use.  
 
Bivariate associations physical symptoms, sleep disturbances and depressive symptoms in 
participants with and without heart failure. 
Table 2 and 3 and presents the associations of physical symptoms, sleep disturbances and 
depressive symptoms in participants with and without HF. In those with HF the physical 
symptoms (i.e. dyspnoea, palpitations and pain) correlated significantly to each others as well 
as to nocturnal awakenings, insomnia symptoms and depressive symptoms. Awakenings 
correlated most strongly with the insomnia symptoms (r=0.360-0.401). Generally the same 
associations and magnitudes of correlations were found in those without HF as well. 
Hypnotics correlated with DMS and NRS in those with HF and with DIS, DMS and NRS in 
those without HF. In those with HF the highest correlation was found between the insomnia 
symptoms NRS and DIS (r=0.559) whereas in those without HF the highest correlation of 
0.554 was between NRS and DMS. No signs of multicollinearity were found from 
inspection of the correlation plots, violation inflation factors or tolerance statistics. 
 
Modelling the associations between physical symptoms, sleep disturbances and depressive 
symptoms in participants with and without heart failure  
We first created a SEM model that explored the relationships between physical symptoms, 
sleep disturbances and depressive symptoms in participants with HF. In the next step this 
model was tested in the group without HF. The associations between dyspnoea, palpitations, 
pain, sleep disturbances and depressive symptoms were then analyzed. The initial SEM 
analysis in participants with HF did not fully confirm the assumed paths and the fit from the 
model were not acceptable. After scrutinizing the data and suggested modification indices, the 
single variables of night-time dyspnoea and palpitations were amalgamated into one latent 
factor labeled cardiopulmonary symptoms.  
The new model, shown in Figure 2, fit the data well in those with HF. Examination of the fit-
indices showed that the model explained the covariances between the manifest variables 
almost completely. Indirect and total effects between the factors in the model are shown in 
Table 4. In those with HF we found moderate direct effects of cardiopulmonary symptoms 
and pain on sleep disturbances (β=0.38 and β=0.37). Sleep disturbances had a strong effect 
(β=0.64) on depressive symptoms. By these paths, cardiopulmonary symptoms and pain had 
moderate indirect effects on depressive symptoms (β=0.24 and β=0.24).  
The model also fit well in those without HF (Figure 3). In this model, cardiopulmonary 
symptoms had a moderate effect on sleep disturbances (β=0.30) and there was a moderate 
effect of sleep disturbances on depressive symptoms (β=0.45). The indirect effect of 
cardiopulmonary symptoms on depressive symptoms was small (β=0.13). Comparing these 
effects to the model of those with HF illustrated that the path between sleep disturbances and 
depressive symptom was significantly lower in those without HF (β=0.45 vs. β=0.64, 
p=0.006). The direct effect of pain on sleep disturbances and the indirect effect of pain on 
depressive symptoms was however of almost the same magnitude as in those with HF (β=0.40 
and β=0.18).  
Discussion  
In the present study of community dwelling older adults with and without HF we found that 
the physical symptoms of dyspnea, palpitations (cardiopulmonary symptoms) and pain were 
directly associated sleep disturbances, which led to an indirect association to depressive 
symptoms. These results suggest that interventions focused on the relief of physical symptoms 
may decrease sleep disturbances and depressive symptoms, regardless of the medical 
diagnosis. Further, depressive symptoms in older adults should be approached as indicators of 
a potentially modifiable condition—impaired sleep.  
We found that cardiopulmonary symptoms were directly associated with sleep disturbances 
and indirectly associated with depressive symptoms in those with and without HF. Others 
have shown that wheezing or whistling from chest at night is a common sleep disturbance 
among older adults and associated with daytime sleepiness.27 The only difference we found in 
those with HF was that the associations between cardiopulmonary symptoms, sleep 
disturbances and depressive symptoms were stronger. Cardiopulmonary symptoms may signal 
sleep disordered breathing (SDB), which is common in community dwelling elders, but even 
more common among elders with HF.28 SDB is known to cause nocturia29 and disturbed sleep 
and in older adults severe SDB has been shown to cause daytime sleepiness.27 It is known that 
SDB in HF is associated with increased risk for having daytime and night time ventricular 
arrhythmias30 as well as to cause choking spells and hyperventilation during sleep.31 SDB 
may therefore be a potential explanation for the stronger associations between 
cardiopulmonary symptoms, sleep disturbances and depressive symptoms in the HF model.  
The association between SDB and self-reported sleep quality in HF patients, however, 
remains unclear at this time. Redeker and colleagues showed only a weak association between 
SDB and self-reported sleep in 170 HF patients, despite the fact that SDB was associated with 
poorer objectively measured sleep quality.32 In two smaller studies of HF patients, however, 
one found that SDB was associated with poorer subjectively rated sleep quality and 
depressive symptoms,33 whereas in the other study, SDB was associated with poor quality of 
life.34 Patients with HF and SDB successfully treated with Continuous Positive Airway 
Pressure (CPAP) have been found to have reductions in night time ventricular arrhythmias.35 
However, the extent of which CPAP treatment of SDB in older adults with as well as without 
HF can improve cardiopulmonary symptoms, sleep disturbances or depressive symptoms is 
unclear. 
As many as 75% of community dwelling elderly report some pain, of these 52% report daily 
pain.36 Despite this, pain is seldom included as a variable in studies investigating correlates or 
predictors of sleep in community dwelling elderly.17, 37-38 In the present study pain during the 
night was associated with sleep disturbances and depressive symptoms, and the magnitude of 
the relationship was the same in those with and without HF. A recent study showed that older 
adults reporting severe pain had an increased risk for poor sleep.39 Furthermore, in older 
adults, pain or physical discomfort at night has been found to be a strong predictor for 
daytime sleepiness.27 Pain and sleep disturbances seem to have a complex relationship. In an 
experimental study of healthy volunteers, disrupted sleep was shown to have a hyper 
analgesic effect whereas recovery sleep was associated with analgesic effects.40 A population 
based study of adults aged 25-65 years showed that baseline self-reported good sleep was a 
predictor for the resolution of pain at 15 months follow-up.41  
The results of this study suggest that reducing cardiopulmonary symptoms, pain and/or sleep 
disturbances are important interventions. Pharmacological treatments of pain and sleep 
problems should however be carefully selected and monitored because of the risk of 
polypharmacy and side-effects such as sedation, drowsiness and somnolence.27, 42 Further, 
sleep medications cause depression in older adults, independent of insomnia.43 Older adults 
with HF may be in particular vulnerable for pharmacological side effects. In individuals aged 
80 years and older, HF medications such as beta-blockers, diuretics and ACE/ARB, have been 
associated with insomnia.44 More than two thirds of HF patients have been found to 
experience an adverse drug event and these patients also report more sleeping problems 
compared to those who have not experienced an adverse drug event.45 Adverse drug events 
may provide another explanation for the stronger association between sleep disturbances and 
depressive symptom in those with HF. Assessment of disturbed sleep as a potential side-effect 
of the pharmacological treatment is important because simply adjusting dosages may improve 
sleep quality. A nonpharmacologic treatment of pain could be CPAP. A small study in older 
adults with SDB found that CPAP therapy had analgesic effects as well as improving 
respiratory parameters.46 Cognitive behavioural therapy (CBT) is another potential approach 
to pain, sleep disturbances, and depressive symptoms. In older adults with arthritis or chronic 
obstructive lung disease and insomnia, CBT has been found to improve sleep and pain.47-48 In 
patients with HF, mindfulness meditation improves depressive symptoms and health-related 
quality of life.49 However, the numbers of CBT studies performed on older adults with and 
without HF are small and few and more large scaled studies are needed. 
 
Limitations 
Depressive symptoms overlap with some physical symptoms such as fatigue and problems 
with appetite, which complicates the interpretation of findings. For this reason we chose the 
HADS because it was specifically developed for measuring depressive symptoms in people 
with different types of chronic diseases. Moreover studies have shown that the somatic 
symptom profile of patients with HF and other chronic diseases and depression is similar to 
that of people with depression only.50-51 However, the association between insomnia and 
depression is complex, both among individuals with heart failure and those without. 
And, paths in a SEM analysis can be directed in different ways. SEM is most useful in 
testing a theory-based model, as specified in this study.3, 14-16, 25 Creating separate models 
investigating different solutions for individuals with and without HF was important so 
that we could identify generic responses versus those that are specific to heart failure. 
Although our model produced a good fit, the study was limited in that the cross-
sectional data limits the possibility of identifying causal directionality. We also used self-
reported symptoms of depression and disturbed sleep instead of objective clinical data 
on sleep and depressive disorders. Many patients who would not meet the diagnostic 
criteria for either of these disorders nevertheless may have scored high on the 
questionnaires used in the study. Some of the attrition was due to death or moving to 
nursing homes; HF, sleep disturbances, and/or depression may have played a role in these 
events. Consequently, a model fitted on data from the remaining subjects may therefore be 
biased in ways that would be difficult to ascertain. An advantage with the study design was 
that it allowed us to explore the associations between physical symptoms, sleep disturbances 
and depressive symptoms in participants with and without HF who were of the same age and 
living in the same area. Another advantage was that all participants were examined by an 
experienced cardiologist, both clinically and with Doppler echocardiography. 
Echocardiography data were incomplete for 9% of the sample and these subjects were 
deleted from the analysis since multiple imputation on data such as echocardiography 
can be misleading. We think therefore that despite the limitations, this study can offer 
important information regarding the impact of physical symptoms on sleep disturbances and 
depressive symptom in community dwelling older adults.  
 
Conclusion 
In older adults living in the community, with and without HF, cardiopulmonary symptoms 
and pain were directly associated with sleep disturbances, which led to a relationship between 
physical and depressive symptoms. Sleep disturbances were more strongly associated with 
depressive symptoms in older adults with HF, suggesting that poor sleep may be a particularly 
important area for focus in this population in which depression is so common. Screening for 
sleep disturbances and depression may alert clinicians to the presence of night time physical 
symptoms in older adults. Pharmacological and/or non-pharmacological interventions can be 
used to reduce cardiopulmonary symptoms and/or pain as well as sleep disturbances and/or 
depressive symptoms. We recommend that clinicians assess the side-effects of cardiovascular 
drugs on patients’ sleep and tailor the treatment regimen in those patients who have sleeping 
problems. Future research is needed testing the impact of CPAP for SDB on physical 
symptoms, sleep, and depressive symptoms. The results of this study illustrate that 
interventions focused on addressing symptoms, regardless of the medical diagnosis, may 
improve sleep quality and depressive symptoms in older adults. However large randomised 
controlled studies are however needed to evaluate the effect of such programs.  
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Tables  
Table 1. Background characteristics for the study population with or without heart failure  
 
Note:ACEI/ARB – Angiotensin converting inhibitor/Angiotensin receptor blockers: LVEF – 
Left ventricular ejection fraction 
 
 
 
 
 
 
 Total 
(n=613) 
HF 
(n=107) 
No HF 
(n=506) 
 
Age, mean (SD) 78 (4) 79 (4) 77 (4) 0.001 
Male, sex, % (n) 47 (289) 71 (67) 43 (218) 0.001 
Body mass index, mean (SD) 27.1 (4.2) 27.4 (4.2) 27.0 (4.2) 0.33 
Systolic blood pressure, mean (SD) 149 (23) 149 (19) 149 (24) 0.85 
Diastolic blood pressure, mean (SD) 75 (11) 75 (10) 75 (12) 0.91 
Diabetes, % (n) 99 (16) 25 (27) 14 (72) 0.005 
Hypertension, % (n) 474 (78) 76 (80) 78 (394) 0.56 
Ischemic heart disease, % (n) 26 (161) 50 (54) 21 (107) 0.001 
Previous or present tumour, % (n) 16 (100) 20 (21) 16 (79) 0.31 
Respiratory disease, % (n) 15 (93) 19 (20) 14 (73) 0.27 
≥ 2 co morbidities, % (n) 46 (284) 64 (68) 36 (38) 0.001 
Creatinine µmol/L , median (25th-75th quart) 74 (63-90) 84 (70-107) 73 (61-87) 0.001 
LVEF<50%, % (n) 132 (22) 107 (100) 5 (25) 0.001 
ACE/ARB, % (n) 26 (158) 39 (42) 23 (116) 0.001 
B-blockers, % (n) 36 (222) 55 (59) 32 (163) 0.001 
Diuretics, % (n) 35 (216) 46 (49) 33 (167) 0.012 
Antidepressants, % (n) 4 (24) 2 (2) 22 (4) 0.41 
Hypnotics, % (n) 6 (35) 8 (8) 5(27) 0.38 
Table 2. Bivariate correlations physical symptoms, factors that disturb sleep and depressive symptoms in participants with heart failure (n=107) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: DIS – Difficulties initiating sleep; DMS – Difficulties maintaining sleep;NRS – Non restorative sleep. 
*p<0.05; **p<0.01,  p<0.001*** 
 
 
 
 
 #Awake Dyspnoea 
night-time 
Palpitations 
night-time 
Pain 
night-time 
DMS NRS DIS Depressive 
symptoms 
Antidepressants Hypnotics 
#Awake 1          
Dyspnoea 
night-time 
0.195* 
 
1         
Palpitations 
night-time 
0.300 ** 
 
0.419*** 1        
Pain 
night-time 
0.361*** 
 
0.204* 
 
0.377*** 1       
DMS 0.401*** 0.191* 
 
0.209* 
 
0.346*** 1      
NRS 0.362*** 0.267** 0.402*** 0.413*** 0.495*** 1     
DIS 0.360*** 0.128 0.240* 
 
0.276*** 0.341*** 0.559*** 1    
Depressive 
symptoms 
0.213 * 
 
0.238* 
 
0.374*** 0.231* 
 
0.264** 0.470*** 0.322** 1   
Antidepressants 0.007 
 
0.06 0.006 -0.049 0.007 0.027 0.056 0.069 1  
Hypnotics 0.07 -0.002 0.041 0.095 0.215* 
 
0.252** 0.157 0.143 -0.039 1 
 
Bivariate correlations physical symptoms, factors that disturb sleep and depressive symptoms in participants without heart failure (n=504) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: DIS – Difficulties initiating sleep; DMS – Difficulties maintaining sleep;NRS – Non restorative sleep. 
*p<0.05; **p<0.01,  p<0.001*** 
 
 
 #Awake Dyspnoea 
night-time 
Palpitations 
night-time 
Pain 
night-time 
DMS NRS DIS Depressive 
symptoms 
Antidepressants Hypnotics 
#Awake 1          
Dyspnoea 
night-time 
0.195*** 
 
1         
Palpitations 
night-time 
0.159*** 
 
0.442*** 1        
Pain 
night-time 
0.305*** 
 
0.292*** 
 
0.313*** 1       
DMS 0.541*** 0.243*** 
 
0.211*** 
 
0.328*** 1      
NRS 0.343*** 0.304*** 0.248*** 0.372*** 0.554*** 1     
DIS 0.247*** 0.192*** 0.168*** 
 
0.268*** 0.422*** 0.474*** 1    
Depressive 
symptoms 
0.176*** 
 
0.222*** 
 
0.171*** 0.207*** 
 
0.212*** 0.324*** 0.160*** 1   
Antidepressants -0.023 
 
0.029 0.065 0.045 0.051 0.166*** 0.098* 0.074 1  
Hypnotics 0.023 -0.054 0.113* 0.098* 0.179*** 
 
0.197*** 0.235*** 0.079 0.165** 1 
 
           
 Table 4. Significant indirect and total effects (β) between factors in the structural equation model in participants with heart failure. Indirect effect 
is the difference between the direct and total effect. 
 
HF group Sleep 
disturbances 
 
Depressive 
Symptoms 
 
Ind. 
effect 
Tot. 
effect 
Ind. 
effect 
Tot. 
effect 
Cardiopulmonary 
Symptoms 
- 0.38 0.24 0.24 
Pain 
 
 0.37 0.24 0.24 
Sleep disturbances 
 
- - - 0.64 
Non HF group     
Cardiopulmonary 
Symptoms 
 0.30 0.13 0.13 
Pain 
 
 0.40 0.18 0.18 
Sleep disturbances 
 
   0.45 
 
 
